Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model.
Salillas S, Raaijmakers J, Aarnoutse RE, Svensson EM, Asouit K, van den Hombergh E, Te Brake L, Stemkens R, Wertheim HFL, Hoefsloot W, van Ingen J. Salillas S, et al. Among authors: wertheim hfl. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0115723. doi: 10.1128/aac.01157-23. Epub 2024 Jan 23. Antimicrob Agents Chemother. 2024. PMID: 38259101 Free PMC article.
The potential role of drug transporters and amikacin modifying enzymes in M. avium.
Schildkraut JA, Coolen JPM, Ruesen C, van den Heuvel JJMW, Aceña LE, Wertheim HFL, Jansen RS, Koenderink JB, Te Brake LHM, van Ingen J. Schildkraut JA, et al. Among authors: wertheim hfl. J Glob Antimicrob Resist. 2023 Sep;34:161-165. doi: 10.1016/j.jgar.2023.07.007. Epub 2023 Jul 13. J Glob Antimicrob Resist. 2023. PMID: 37453496 Free article.
The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease.
Schildkraut JA, Raaijmakers J, Aarnoutse R, Hoefsloot W, Wertheim HFL, van Ingen J. Schildkraut JA, et al. Among authors: wertheim hfl. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0087423. doi: 10.1128/aac.00874-23. Epub 2023 Oct 25. Antimicrob Agents Chemother. 2023. PMID: 37877693 Free PMC article.
Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance.
Zakhour J, Haddad SF, Kerbage A, Wertheim H, Tattevin P, Voss A, Ünal S, Ouedraogo AS, Kanj SS; International Society of Antimicrobial Chemotherapy (ISAC) and the Alliance for the Prudent Use of Antibiotics (APUA). Zakhour J, et al. Int J Antimicrob Agents. 2023 Jul;62(1):106816. doi: 10.1016/j.ijantimicag.2023.106816. Epub 2023 Apr 13. Int J Antimicrob Agents. 2023. PMID: 37061101 Free article. Review.
Occurrence and predictors of laboratory abnormalities during outpatient parenteral antimicrobial therapy - A multicenter cohort study to inform laboratory test monitoring.
Stoorvogel HH, van Egmond M, Wertheim HFL, Schouten JA, Hulscher MEJL, Peeters L, Kiers Y, Koenders S, Sprong T, van Mens SP, Tromp M, Richel O, Akkermans R, Ten Oever J. Stoorvogel HH, et al. Among authors: wertheim hfl. J Infect. 2024 Nov;89(5):106301. doi: 10.1016/j.jinf.2024.106301. Epub 2024 Sep 30. J Infect. 2024. PMID: 39357569 Free article.
Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure.
Versporten A, Gyssens IC, Pulcini C, Monnier AA, Schouten J, Milanic R, Stanic Benic M, Tebano G, Le Maréchal M, Zanichelli V, Huttner B, Vlahovic-Palcevski V, Goossens H, Hulscher ME, Adriaenssens N; DRIVE-AB WP1 group. Versporten A, et al. J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi59-vi66. doi: 10.1093/jac/dky119. J Antimicrob Chemother. 2018. PMID: 29878220 Free PMC article.
183 results